Part 1 of a 2 part series
Evolving how clinicians interact with patients is a top priority in the Healthcare industry today. At Point of Care Decision Support (PCDS), we understand the importance of delivering solutions that facilitate strong communication between patients and caregivers.
We are working with technology and medical professionals to connect clinicians at the point of care with actionable information to promote patient engagement, medication dosing best practices (for volatile medications such as warfarin), and measuring outcomes that are vital to patient safety and improved treatment plans across diverse health systems.
We believe strongly that outcomes should be objective and easily understood in context to be effective. With all the information healthcare technology professionals make available to clinicians to provide quality care, PCDS partners with clinical leaders, CIO’s and their teams to facilitate the following:
- Access to focused information the clinician needs to quickly assess a patient’s health
- Review of patient treatment plan trends
- Identification of patients at high risk
- Availability of evidence-based guidelines to support dosing decisions
PCDS enables greater efficiency and effectiveness of care through meaningful and measurable presentation of key elements impacting positive clinical outcomes. Leveraging examples from our Anticoagulation (AC) solution, we will briefly address each measurable element below.
Focused information the clinician needs to quickly assess a patient’s health
The ability to quickly and efficiently assess a patient’s health status and risk level while taking an anticoagulant is vital to patient engagement and outcomes. A comprehensive treatment plan for a patient on warfarin includes evaluating the Time in Therapeutic Range (TTR) over the last 90 days. To assess the effectiveness of a treatment plan, the first view a clinician needs to see is a quick dashboard summary that captures critical pieces of information related to a patient’s anticoagulation management that can be digested in less than 60 seconds. The dashboard summary should include basic information on the patient’s primary and secondary diagnosis, a treatment summary, and INR, CrCl and TTR trends using graphs and charts. INR trends over time can be represented in conjunction with the target INR range and the corresponding TTR. Taking it a step further, graphics should include tracking medication compliance and display the actual dose taken by the patient (notated in red) compared to what was prescribed. See the following screen shot demonstrating these important dashboard features.
As you can see, the clinician can quickly gain a complete view of the patient’s current condition based on TTR and the chronological view of INR labs and swiftly assess if the health of a patient is trending positively or negatively.
Review patient treatment plan trends
One of the challenges clinicians face is having all the relevant information they need in a concise view for treating specialty conditions such as anticoagulation therapy. Management of medications in a care plan can be especially challenging. Clinicians benefit from having a combination of historical perspective of dosing schedules as well as current dosing schedule considerations when setting the next dosing schedule. When trend analysis is easily ascertained as part of setting the next dosing schedule, clinicians have a view of the patient that is sometimes difficult to pull together in systems available to them today, or they need to go to multiple views to gain that perspective, taking time and distracting care providers from their patients while they “fish” for a more complete view of a treatment plan results.
PCDS AC enables clinicians to easily see the four most recent dosing schedules complete with missed doses as well as the current dose schedule while they are setting the next dosing schedule for a patient.
The following screen shot outlines these key features.
What patient information are you missing today that would help you monitor and provide a more complete treatment plan for your anticoagulation patients?
In part 2, we will cover how Point of Care AC identifies patients at risk and how evidence-based guidelines support drug dosing decisions.